Vol. 23No. 163 42 HPV HPV 1113 HPV 42 HPV HPV HPV 1 1 510 1020 HPV 1020 510 HIV 0.1 0.005 HIV 2030 HIV 0.2 510 HPV 1020 15 HIV 2030 HIV HIV 0.2 0.1 Takeyuki Sato 2608677 181
64 2011 2 1 1518 6,000 513 2 2004 2005 979 20.8 1,023 25.75 n55 9.1 n128 3.94 0.005 3 5 1 152 253 35 6,7 1 25 4 75 n149 8.7 n267 4.89 2004 27.8 1642 2005 23.52 1538 1 2 13 510 1 20 20 30 1 8 510 2 300 1 3 20 20 1 g 1 7 1 g HPV 1 HPV HPV DNA
Vol. 23No. 165 1 18422 510 8 3 1 300 3,000 1,000 1 g 1 1 g 1 HPV 2L12 E67 2 E6 P53 E7 RB HPV 2HPV 3 90
66 2011 3HPV 4HPV 204 1835 1 1 1 68 61 21 54 204 2 HPV 3,4 HPV 4.4 10.3 6.6 6.6 0 4.8 0 0 3.4 6.8 1 HPV 611 20 1618 15 HPV 4 1 2 4 5 HPV 2 HPV 5 9 HPV 3 HPV 2007
Vol. 23No. 167 4 n718 611 1618 HPV 199 27.7519 72.3 5 3 RRP 4 HPV 611 14 10 0.24 24 1.11 10 10 HPV HPV 5 HPV HC2Hybrid Capture 2 types13 9 4 HPV 1 7,000 2,500 HPV 2030 10 2 HPV 110 30 2004 2 1 20 HPV 20 80 20 HPV 2 HPV 5 2040 HPV 11 HPV
68 2011 5 HPV 2008 36,000 7,600 22 HPV 16 87 HPV 1112 HPV HPV 20 20 2040 HPV 20 80 20 074 13 6HPV Gardasil 4 611 1618 2006 6 FDA 120 2010 5 2011 926 1112 2007 2011 Cervarix 2 1618 2009 FDA 106 2010 2 1045 2009 12 12 20 HPV 13 5 HPV HPV 2 4 1416 16 18 2 611 4 4 RRP 2 80 1618 611 2 90 6 4 2006 2 2 4 2011 4 2 4 HPV 17 18 913 4 26 2 45 HPV HPV HPV
Vol. 23No. 169 7 HPV 1 1618 30 2 3 4 HPV 5 82 4 2 4 1618 4 2011 611 1618 2 2009 4 HPV HPV 4 120 2 106 HPV 7 HPV HPV HPV HPV 4 HPV 4 2 4 8 4 5 9 2
70 2011 9 5 23 1 15 797 961 1329 9 10 8 HPV 15 OK 15 9 1989 1994 5 12 19 HPV 10HIV optout CDC 2006 1364 optout HIV 0.1 19 15 HPV opt out HIV optout 20 Optout opt out HIV HIV HIV HIV 0.1 10 1364
Vol. 23No. 171 6 optout HIV HIV 0.1 HIV optout HIV HIV 1 510 optout 3 EIA IgG HIV 100 11 EIAIgG HBsAgHBsAbHBcAbHCV TPHARPR HIV HIV 100 6 2 1 HPV HBV 11 MSMmen who have sex with men HPV
72 2011 1 Optout HIV optout 2 2 brief counselingbrief behavioral interventions 21 3 5 HPV 22 1 15 17 2006 2 21 2010 3HPV 281151222010 4 71132513322008 5 1460682003 6HIV HIV 17 2006 7 PTA 16 2005 8 2002 1517452004 9Onuki M, et alhuman papillomavirus infections among Japanese womenagerelated prevalence and typespecific risk for cervical cancer. Cancer Sci 10013121316, 2009 10Campisi P, et althe epidemiology of juvenile onset recurrent respiratory papillomatosis
Vol. 23No. 173 Derived from a population level national database. Laryngoscope 12012331245, 2010 11Dayyani F, et almetaanalysis of the impact of human papillomavirushpvon cancer risk and overall survival in head and neck squamous cell carcinomashnscc. Head & Neck Oncol 215 25, 2010 12Ang KKHuman papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 3632435, 2010 13Ioannis N, et alvaccination against human papilloma virus HPVEpidemiological evidence of HPV in nongenital cancers. Pathol Oncol Res On line18 July, 2010 14Paavonen J, et alefficacy of a prophylactic adjuvanted bivalent L1 viruslikeparticle vaccine against infection with human papillomavirus types 16 and 18 in young womenan interim analysis of a phase doubleblind, randomised controlled trial. Lancet 36921612170, 2007 15Garland SM, et alquadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 35619281943, 2007 16 71133313382008 17 HPV HPV 1 2010 18HPV 2011 19 2091952009 20CDCRevised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR 50No. RR19 6385, 2006 21Carey MP, et albrief and intensive behavioral interventions to promote sexual risk reduction among STD clinic patientsresults from a randomized controlled trial. AIDS Behav 14504 517, 2010 22 2011 2011 11